CT
PGEN icon

Cambridge Trust’s Precigen PGEN Stock Holding History

Cambridge Trust’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4 Hold
3
– – ﹤0.01% 655
2023
Q4 		$4 Hold
3
– – ﹤0.01% 687
2023
Q3 		$4 Hold
3
– – ﹤0.01% 708
2023
Q2 		$3 Hold
3
– – ﹤0.01% 694
2023
Q1 		$3 Hold
3
– – ﹤0.01% 760
2022
Q4 		$0 Hold
3
– – ﹤0.01% 856
2022
Q3 		$0 Hold
3
– – ﹤0.01% 885
2022
Q2 		$0 Hold
3
– – ﹤0.01% 931
2022
Q1 		$0 Hold
3
– – ﹤0.01% 1103
2021
Q4 		$0 Buy
+3
New +$13 ﹤0.01% 1116

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Trust's PGEN Position: Q1 2024 in Review

Cambridge Trust held its Precigen (PGEN) position steady in Q1 2024 at 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #655.

Cambridge Trust first reported a position in PGEN in Q4 2021 and has held it in 10 quarters since. 130 funds tracked by Wall St. Rank hold PGEN as of Q1 2024.

  • Cambridge Trust held 3 shares of Precigen worth $4 as of Q1 2024.
  • Cambridge Trust left its Precigen share count unchanged in Q1 2024.
  • Precigen made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #655 holding.
  • Cambridge Trust first reported a position in Precigen in Q4 2021 and has held it in 10 quarters since.
  • 130 funds tracked by Wall St. Rank held Precigen as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.